PMDA drug package insert
マイラックスα
PMDA OTC drug · 新日製薬株式会社 · package insert Sep 27, 2025
Key facts
| Brand names | マイラックスα |
|---|---|
| Companies | 製造販売元／（株）アラクス,販売会社／新日製薬株式会社 |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | 瀉下薬（下剤） |
| Package insert date | Sep 27, 2025 |
| PMDA document key | 100387_K2509000012 |
| PMDA company code | 100387 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: